In this study, we concluded that dictamnine inhibits osteoclastogenesis by inhibiting the activities of ROS, NF-κB, and NFATc1 in vitro and deters the development of OVX-induced osteoporosis mouse models. The gene discussed is NFATC1; the disease is osteoporosis.